[Cytokine storm in avian influenza]
- PMID: 18697437
[Cytokine storm in avian influenza]
Abstract
The most dramatic example of defining the pathogenicity of influenza virus A/H5N1 strains is the higher fatality rate of avian influenza epidemic (>50%) occured in Southeast Asia in 1997 comparing to the pandemic caused by influenza virus A/H1N1 in 1918 (5-10%) which was recorded as the most destructive pandemic in the world. When considering the fatal/total case numbers (208/340) reported by World Health Organization in respect of December 14th, 2007, the mortality rate has now reached to 61 percent. Recent studies have shown that the high fatality rate of avian influenza virus infections is a consequence of an overactive inflammatory response and the severity of infection is closely related with virus-induced cytokine dysregulation. The most important feature of A/H5N1 immunopathogenesis is the appearence of hypercytokinemia ("cytokine storm") which is characterized by the extreme (exaggerated) production and secretion of large numbers and excessive levels of pro-inflammatory cytokines. This phenomenon is blamed on the emergence of lethal clinical symptoms such as extensive pulmonary oedema, acute bronchopneumoniae, alveolar haemorrhage, reactive haemophagocytosis, and acute respiratory distress syndrome, associated with necrosis and tissue destruction. Numerous in vitro, in vivo and clinical studies have pointed out that A/H5N1 viruses are very strong inducers of various cytokines and chemokines [Tumor Necrosis Factor (TNF)-alpha, Interferon (IFN)-gamma, IFN-alpha/beta, Interleukin (IL)-6, IL-1, MIP-1 (Macrophage Inflammatory Protein), MIG (Monokine Induced by IFN-gamma), IP-10 (Interferon-gamma-Inducible Protein), MCP-1 (Monocyte Chemoattractant Protein), RANTES (Regulated on Activation Normal T-cell Expressed and Secreted), IL-8], in both humans and animals. The privileged cells of cytokine storm are macrophages and CD8+ T-lymphocytes, while the primary contributor cytokines are TNF-alpha, IL-6 and IFN-gamma. It has been detected that, mutations of some viral genes (NS1, PB2, HA and NA) are responsible for the cytokine storm, by increasing the viral replication rate, expending the tissue tropism, facilitating the systemic invasion and emerging of resistance against the host antiviral response. It has been shown that Glu92 and Ala149 mutations, and carboxyl-terminal ESEV/EPEV motif of NS1 protein have been implicated as determinants of virulence for A/H5N1 strains. In addition, Lys627 mutation in PB2 protein, polybasic aminoacid mutations in the cleavage region of hemagglutinin (HA) polyprotein, and glycosylation and sialylation mutations in HA and neuraminidase (NA) proteins were found to enhance the immune-mediated patology of highly virulent A/H5N1 strains. In this review article, the immunopathogenesis of influenza infection and the mechanisms of cytokine storm caused by influenza A/H5N1 viruses have been discussed under the light of recent literature.
Similar articles
-
Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.Vaccine. 2007 Oct 16;25(42):7379-84. doi: 10.1016/j.vaccine.2007.08.011. Epub 2007 Aug 24. Vaccine. 2007. PMID: 17870216
-
Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1).Vaccine. 2009 Dec 9;27(52):7451-8. doi: 10.1016/j.vaccine.2009.05.014. Epub 2009 May 29. Vaccine. 2009. PMID: 19450640
-
Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.Clin Infect Dis. 2007 Sep 15;45(6):723-31. doi: 10.1086/520981. Epub 2007 Aug 8. Clin Infect Dis. 2007. PMID: 17712756
-
The role of cytokines in the immune response to influenza A virus infection.Acta Virol. 2006;50(3):151-62. Acta Virol. 2006. PMID: 17131933 Review.
-
[Influenza type A (H5N1) virus infection].Mikrobiyol Bul. 2007 Jul;41(3):485-94. Mikrobiyol Bul. 2007. PMID: 17933264 Review. Turkish.
Cited by
-
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Eur J Clin Pharmacol. 2012 May;68(5):479-503. doi: 10.1007/s00228-011-1161-x. Epub 2011 Nov 22. Eur J Clin Pharmacol. 2012. PMID: 22105373 Review.
-
Metabolic pathways of lung inflammation revealed by high-resolution metabolomics (HRM) of H1N1 influenza virus infection in mice.Am J Physiol Regul Integr Comp Physiol. 2016 Nov 1;311(5):R906-R916. doi: 10.1152/ajpregu.00298.2016. Epub 2016 Aug 24. Am J Physiol Regul Integr Comp Physiol. 2016. PMID: 27558316 Free PMC article.
-
Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: a comparative analysis between highly pathogenic and modified H5N1 viruses.Virol J. 2010 Sep 9;7:219. doi: 10.1186/1743-422X-7-219. Virol J. 2010. PMID: 20828378 Free PMC article.
-
Long-term respiratory follow-up of H1N1 infection.Virol J. 2011 Jun 25;8:319. doi: 10.1186/1743-422X-8-319. Virol J. 2011. PMID: 21702977 Free PMC article.
-
Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets.Sci Rep. 2015 Nov 3;5:15940. doi: 10.1038/srep15940. Sci Rep. 2015. PMID: 26526113 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous